Deputy Executive Director, Wits Reproductive Health and HIV Institute, University of the Witwatersrand
Dr Venter is the Deputy Executive Director of the Wits Reproductive Health and HIV Institute at the University of the Witwatersrand. He leads multiple antiretroviral treatment optimisation studies, and has an active interest in public sector access to HIV services. He is currently working on new first and second line antiretroviral options, patient linkage to care interventions, and self-testing projects. Previously, he lead large PEPFAR-funded HIV programmes in South Africa, including one that focused on truckers and sex workers. He has been represented on South African and regional guidelines for over a decade, having done almost all his training within South Africa.
His major research currently focus on low dose stavudine, low dose darunavir in second line treatment, and combinations of newer drugs to improve the resistance and potency of first line, as well as using patient information to drive improved linkage to care after diagnosis.
South Africa's COVID-19 strategy needs updating: here's why and how
May 14, 2020 10:08 am UTC| Economy
Decision-making at the early stages of the SARS-CoV-2 pandemic (the coronavirus causing COVID-19) was constrained by a paucity of medical evidence and epidemiological data. Knowledge gained over the past two months can...
A sustainable future begins at ground level
Canada needs a national strategy for homeless refugee claimants
An eclipse for everyone – how visually impaired students can ‘get a feel for’ eclipses